Belgium· BE-AMP-SAM038884-00
Zincfrin 2.5 mg/ml - 1.2 mg/ml
A phenylephrin, kombinationen product containing zinc sulfate, registered in Belgium by Novartis Pharma. The same ATC class is registered in 2 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Phenylephrin, kombinationen is registered in 2 of 19 countries.
Countries holding a registration under ATC S01GA55 (phenylephrin, kombinationen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Phenylephrin, kombinationen · ATC S01GA55
2 / 19 countries
- Belgiumprice
- Finlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Zinc Sulfate
- Manufacturer
- Novartis Pharma
- Country
- Belgium (BE)
- ATC code
- S01GA55
- ATC class
- Phenylephrin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Phenylephrin, kombinationen in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandOftan-ZinkSanten Oy
- United KingdomAactizinc 125mg effervescent tabletsTriOn Pharma Ltd
- United Stateszinc sulfateZydus Lifesciences Limited
- Japan硫酸亜鉛水和物
- SwitzerlandVirudermin, Gelsteinberg pharma ag
- PolandZincteralTeva Pharmaceuticals Polska Sp. z o.o.
- SwedenSolvezink 45 mg Zn 2+ BrustablettKaro Pharma AB
- NorwaySolvezinkKaro Pharma AB (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Zinc Sulfate
- Norway · Solvezink
- Sweden · Solvezink
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7f9d1925-9712-4b5a-aaff-5c9d934d95fb GET /v1/drugs/7f9d1925-9712-4b5a-aaff-5c9d934d95fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Zincfrin 2.5 mg/ml - 1.2 mg/ml",
"name_fr": "Zincfrin 2.5 mg/ml - 1.2 mg/ml",
"name_nl": "Zincfrin 2.5 mg/ml - 1.2 mg/ml",
"amp_code": "SAM038884-00",
"strengths": [
"2.5000",
"2.5000",
"1.2000",
"2.5000",
"1.2000",
"1.2000"
],
"pack_count": 1,
"substances": [
"Zinc Sulfate",
"Phenylephrine Hydrochloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Phenylephrine, Combinations",
"authorisation_numbers": [
"BE038884"
]
}See everything about phenylephrin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.